Intimate Brands buyout
This article was originally published in The Rose Sheet
Executive Summary
Intimate Brands to begin merging into a subsidiary of The Limited March 21 after close of trading, company announces March 21. Move comes after 72.6 mil. IBI shares were tendered to The Limited as part of the company's stock repurchase offer, giving The Limited a 98% stake in Intimate Brands. The Limited announced the buy-back plan Feb. 5, but later sweetened its offer after several IBI shareholders filed lawsuits alleging the terms undervalued the company. An outside review panel appointed by IBI recommended shareholders accept the stock swap, which is valued at $1.56 bil. (1"The Rose Sheet" March 18, 2002, p. 4)...
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.